| Recruiting | Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants Non-Alcoholic Fatty Liver Disease | N/A | 2024-01-31 |
| Active Not Recruiting | Effect of the Food Supplement TOTUM-070 on Lipid Metabolism Hypercholesterolemia | N/A | 2023-10-04 |
| Completed | Determination of Biological Activity of Enriched Serum Following TOTUM-448 Consumption NAFLD, MASLD, Mild Inflammatory Context | N/A | 2023-09-27 |
| Terminated | Effects of 6 Weeks TOTUM-070 on Lipid Metabolism and Cardiovascular Health in Individuals at Increased Cardio- Hypercholesterolemia, Cardiovascular Risk Factor, Dyslipidemias | N/A | 2022-12-14 |
| Active Not Recruiting | Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure Prehypertension, Elevated Blood Pressure, Blood Pressure | N/A | 2022-07-15 |
| Unknown | To Assess TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure Elevated Blood Pressure | N/A | 2022-05-30 |
| Completed | Mode of Action (MoA) Study of TOTUM-63 in Individuals at Increased Cardio-metabolic Risk Prediabetic State, Dysglycemia, Overweight and Obesity | N/A | 2022-04-25 |
| Completed | Effect of Totum-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects Hypercholesterolemia, Cardiovascular Risk Factor, Dyslipidemias | N/A | 2021-02-17 |
| Completed | Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT) Prediabetic State, Diabetes type2, Dysglycemia | N/A | 2020-07-08 |
| Completed | Tolerance Study of the Dietary Supplement Lipidrive (ECPH1-03) Obese | Phase 1 / Phase 2 | 2017-03-02 |
| Completed | Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertrigly Hypercholesterolemia, Hypertriglyceridemia | Phase 1 / Phase 2 | 2017-01-01 |
| Completed | Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabete Prediabetes, Type 2 Diabetes, Hypertriglyceridemia | Phase 2 / Phase 3 | 2016-10-01 |
| Completed | Tolerance Study of the Dietary Supplement Valedia Overweight | Phase 1 | 2016-05-01 |